Bilateral Mammary Artery Graft to Reduce the Chance of Repeat Revascularization

According to previous studies, patients receiving bilateral internal mammary artery conduits during coronary artery bypass grafting have better survival than those receiving a single internal mammary artery. The reason behind this remains unclear, let alone whether there really is lower repeat revascularization rate.

Doble puente mamario para reducir la chance de nuevas revascularizaciones

This analysis compared timing, frequency, and type of repeat coronary revascularization among patients receiving single vs. bilateral internal mammary artery conduits.


Read also: Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?”.


The study included 47,984 consecutive patients undergoing bypass revascularization surgery in 7 centers between 1992 and 2014. 1,482 of these patients received bilateral internal mammary artery conduits.

 

To compare them, patients were propensity matched, which left 1,297 patients in each branch (bilateral vs. single internal mammary artery) for final analyzis. Primary end point was freedom from repeat revascularization.


Read also: Additional Benefit from Radial Artery Graft in Myocardial Revascularization Surgery”.


After a 13.2 year follow up, well matched by age, comorbidities, ventricular function, etc., patients showed that bilateral internal mammary artery conduits are associated with higher freedom from revascularization, compared against single mammary artery conduits (HR= 0.78, CI 95%, 0.65 to 0.94; p=0.009). 19.4% (n=252) of patients in the single mammary artery branch required repeat revascularization at follow up vs. 15.1% (n=196) of patients with bilateral mammary artery conduits (p=0.004).

 

The vast majority of revascularization procedures were PCIs for both groups, the most frequently intervened being the right coronary and the circumflex.

 

In addition, bilateral internal mammary artery conduits were associated with a reduction in all-cause mortality at 12 years (HR, 0.79; p=0.001) and there was no increase in inhospital mortality rate.

 

Conclusion

Bilateral mammary artery conduits were associated with a reduction in repeat revascularization rate and better survival rate at long term, which is why it should be considered more frequently in myocardial revascularization surgery.

 

Editorial Comment

The NEJM has recently published the 5 year ART trial follow up, which randomized CABG patients to bilateral vs. single internal mammary artery grafts. This study, the largest on this matter, was not able to show differences at 5 years, though outcomes at 10 years remain pending. There was increased morbidity among patients receiving bilateral internal mammary artery grafts (sternal infections and need of sternal reconstruction).

 

Original title: Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.

Reference: Alexander Iribarne et al. Circulation. 2017;136:1676–1685.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...